The Existing Drug Nifuroxazide as an Antischistosomal Agent: In Vitro, In Vivo, and In Silico Studies of Macromolecular Targets

Schistosomiasis is a parasitic disease that afflicts approximately 250 million people worldwide. There is an urgent demand for new antiparasitic agents because praziquantel, the only drug available for the treatment of schistosomiasis, is not universally effective and may derail current progress tow...

Descripción completa

Detalles Bibliográficos
Autores principales: Roquini, Vinícius, Mengarda, Ana C., Cajas, Rayssa A., Martins-da-Silva, Milene F., Godoy-Silva, Julia, Santos, Gustavo A., Espírito-Santo, Maria Cristina C., Pavani, Thais F. A., Melo, Vanusa A., Salvadori, Maria C., Teixeira, Fernanda S., Rando, Daniela G. G., de Moraes, Josué
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434008/
https://www.ncbi.nlm.nih.gov/pubmed/37409934
http://dx.doi.org/10.1128/spectrum.01393-23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434008/
https://www.ncbi.nlm.nih.gov/pubmed/37409934
http://dx.doi.org/10.1128/spectrum.01393-23

Ejemplares similares